Skip to content

Study on the Efficacy of Thunder-Fire Moxibustion Combined with Auricular Therapy in Treating Perimenopausal Dry Eye Based on the Theory of 'Yi-Gui Sharing the Same Origin'

Study on the Efficacy of Thunder-Fire Moxibustion Combined with Auricular Therapy in Treating Perimenopausal Dry Eye Based on the Theory of 'Yi-Gui Sharing the Same Origin'

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000275
Enrollment
Unknown
Registered
2025-02-15
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dry eye disease

Interventions

Experimental Group B:Thunder-Fire Moxibustion
Experimental Group A:Auricular Therapy

Sponsors

Nanjing Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for dry eye syndrome in both Traditional Chinese Medicine (TCM) and Western medicine; (2) Meet the diagnostic criteria for the perimenopausal period; (3) Be classified as liver-kidney yin deficiency syndrome according to TCM pattern differentiation; (4) Be aged between 45 and 55 years; (5) Have not used any medications or treatments related to the condition in the past three months; (6) Voluntarily participate in the study and sign an informed consent form; Participants who meet all the above criteria will be included in this trial.

Exclusion criteria

Exclusion criteria: (1) Patients with severe eye diseases such as glaucoma keratitis or a history of ophthalmic surgery in the past 3 months; (2) Patients with severe autoimmune diseases or systemic diseases of the heart brain liver kidneys etc.; (3) Individuals with mental illness who are unable to cooperate; (4) Pregnant or lactating women; (5) Individuals with allergies to moxibustion; (6) Individuals with obvious inflammation or pathology of the auricle or allergies to auricular point pressure therapy; Participants meeting any of the above criteria are not eligible for inclusion in this trial.

Design outcomes

Primary

MeasureTime frame
break-up time;

Secondary

MeasureTime frame
ODSI;Schirmer's Test;corneal fluorescein staining;

Countries

China

Contacts

Public ContactHong Yanyan

Nanjing Hospital of Chinese Medicine

fsyy00210@njucm.edu.cn18951755277

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026